Wanyu L. Lambiv

Stem Cell–Related “Self-Renewal” Signature and High Epidermal Growth Factor Receptor Expression Associated With Resistance to Concomitant Chemoradiotherapy in Glioblastoma

Anastasia Murat, Eugenia Migliavacca, Thierry Gorlia et al. · Journal of Clinical Oncology · 2008 · 728 citations · Full text

Pathway Analysis of Glioblastoma Tissue after Preoperative Treatment with the EGFR Tyrosine Kinase Inhibitor Gefitinib—A Phase II Trial

Monika E. Hegi, Annie‐Claire Diserens, Pierre Bady et al. · Molecular Cancer Therapeutics · 2011 · 189 citations · Full text

Tumor Innervation, Chemoprevention Strategy, Pathology +20

The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence

Wanyu L. Lambiv, Irene Vassallo, Mauro Delorenzi et al. · Neuro-Oncology · 2011 · 122 citations · Full text

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

Monika E. Hegi, Robert-Charles Janzer, Wanyu L. Lambiv et al. · Acta Neuropathologica · 2012 · 83 citations · Full text

Neuro-oncology, Tumoral Pathology, Tumor Heterogeneity +14

ETS-1-mediated Transcriptional Up-regulation of CD44 Is Required for Sphingosine-1-phosphate Receptor Subtype 3-stimulated Chemotaxis

Wenliang Zhang, Jiawei Zhao, Jen-Fu Lee et al. · Journal of Biological Chemistry · 2013 · 23 citations · Full text